Scientific Congresses in Transplant Medicine

Selected Data Presentations

Select "Upcoming" to see a list of future scientific congresses in transplant medicine. Select "Past" to review data and presentations from recent congresses. This is not intended to be a comprehensive resource of all congresses and congress materials across therapeutic and disease areas.

Congress materials may include information about investigational use(s) of compounds/products that are not approved for use by the U.S. Food and Drug Administration (FDA) and/or are inconsistent with the Prescribing Information. Takeda does not recommend the use of any Takeda product beyond the approved labeling. Any decisions regarding the usage of a Takeda product beyond the approved labeling is left to the discretion of the healthcare professional. Takeda makes no representations about whether investigational compounds or unapproved uses will be approved by the FDA.

 

Upcoming & Past Conferences

  • Upcoming

  • Past

American Transplant Congress (ATC), 2024

June 1 - 5, 2024 | Link to Event

A forum for exchange of new scientific and clinical information in solid organ and tissue transplantation, bringing together a wide diversity of transplant professionals.

Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (TCT), 2024

February 21 - 24, 2024

A comprehensive event including a variety of leading experts in the field of transplantation and cellular therapy discussing the latest developments through scientific sessions, oral abstracts and posters.

American Society of Hematology (ASH), 2023

December 9 - 12, 2023

The premier global congress from the world's largest professional society serving both clinicians and scientists working in malignant and classical hematology.

Academy of Managed Care Pharmacy Nexus (AMCP Nexus), 2023

October 16 - 19, 2023

Annual event with more than 2,500 members and non-members of the AMCP to engage on the latest innovations and most intentional networking in managed care pharmacy.

  • A Multinational Study Assessing Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Solid Organ Transplant Recipients With Refractory/Resistant Cytomegalovirus Infection or Intolerance to Anti-Cytomegalovirus Therapy

Livtencity® (maribavir)

  • Multinational Study Assessing Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Hematopoietic Stem Cell Transplant Recipients With Refractory/Resistant Cytomegalovirus Infection, or Intolerance to Anti-Cytomegalovirus Therapies

ID Week, 2023

October 11 - 15, 2023

The joint annual meeting of leading global societies dedicated to infectious disease research and advances.

American College of Clinical Pharmacy (ACCP), 2023

September 10 - 12, 2023

Global conference on clinical pharmacy with the goal of advancing clinical pharmacist roles and responsibilities to optimize pharmacotherapy in the prevention and treatment of disease.

Livtencity® (maribavir)

  • Impact of Time From Transplant to Treatment of Patients With Refractory Cytomegalovirus Infection: Post Hoc Analysis of Phase 3 SOLSTICE Study

American Transplant Congress (ATC), 2023

June 3 - 7, 2023

A forum for exchange of new scientific and clinical information in solid organ and tissue transplantation, bringing together a wide diversity of transplant professionals.

International Society for Heart & Lung Transplantation (ISHLT), 2023

April 19 - 22, 2023

One of the largest gatherings of healthcare practitioners, researchers, and allied health professionals focused on advanced treatment for end-stage heart and lung disease.